This is a timeline previously unheard of in traditional drug development processes.
The candidate has already demonstrated promising results in preclinical studies, which is an encouraging sign of its potential effectiveness.
By reducing the time and resources traditionally required in drug development, Exscientia's approach not only speeds up the process but also promises to make it more efficient and effective.
[
add
]
[
|
|
...
]